Treatment of chronic kidney disease in older populations
Ageing and health. The World Health Organization (WHO). https://www.who.int/news-room/fact-sheets/detail/ageing-and-health.
Understanding the dynamics of the aging process. National Institute on Aging (NIA). https://www.nia.nih.gov/about/aging-strategic-directions-research/understanding-dynamics-aging).
Epidemiology of kidney disease in the United States. US Renal Data System.
Merchant, A. A. & Ling, E. An approach to treating older adults with chronic kidney disease. CMAJ 195, E612–E618 (2023).
Google Scholar
Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709–733 (2020).
Alfano, G. et al. Rethinking chronic kidney disease in the aging population. Life 12, 1724 (2022).
Google Scholar
Moist, L. M. et al. Canadian Organ Replacement Register (CORR): reflecting the past and embracing the future. Can. J. Kidney Health Dis. 1, 26 (2014).
Google Scholar
Pecoits-Filho, R. et al. Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes. Kidney Int. Suppl. 10, e3–e9 (2020).
Google Scholar
Liyanage, T. et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385, 1975–1982 (2015).
Google Scholar
Thurlow, J. S. et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am. J. Nephrol. 52, 98–107 (2021).
Google Scholar
Denic, A. et al. Single-nephron glomerular filtration rate in healthy adults. N. Engl. J. Med. 376, 2349–2357 (2017).
Google Scholar
Denic, A. et al. The substantial loss of nephrons in healthy human kidneys with aging. J. Am. Soc. Nephrol. 28, 313–320 (2017).
Google Scholar
Denic, A., Glassock, R. J. & Rule, A. D. The kidney in normal aging: a comparison with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 17, 137–139 (2022).
Google Scholar
Epstein, M. Aging and the kidney. J. Am. Soc. Nephrol. 7, 1106–1122 (1996).
Google Scholar
Zhou, X. J. et al. The aging kidney. Kidney Int. 74, 710–720 (2008).
Google Scholar
Weinstein, J. R. & Anderson, S. The aging kidney: physiological changes. Adv. Chronic Kidney Dis. 17, 302–307 (2010).
Google Scholar
Wang, X. et al. Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney. Kidney Int. 85, 677–685 (2014).
Google Scholar
Denic, A., Glassock, R. J. & Rule, A. D. Structural and functional changes with the aging kidney. Adv. Chronic Kidney Dis. 23, 19–28 (2016).
Google Scholar
Nitta, K., Okada, K., Yanai, M. & Takahashi, S. Aging and chronic kidney disease. Kidney Blood Press. Res. 38, 109–120 (2013).
Google Scholar
Satoh, M. et al. Mitochondrial damage-induced impairment of angiogenesis in the aging rat kidney. Lab. Invest. 91, 190–202 (2011).
Google Scholar
Lindeman, R. D., Tobin, J. & Shock, N. W. Longitudinal studies on the rate of decline in renal function with age. J. Am. Geriatr. Soc. 33, 278–285 (1985).
Google Scholar
Davies, D. F. & Shock, N. W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J. Clin. Invest. 29, 496–507 (1950).
Google Scholar
Poggio, E. D. et al. Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors. Kidney Int. 75, 1079–1087 (2009).
Google Scholar
Berg, U. B. Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrol. Dial. Transpl. 21, 2577–2582 (2006).
Google Scholar
Messerli, F. H. et al. Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet 2, 983–986 (1983).
Google Scholar
Luft, F. C., Grim, C. E., Fineberg, N. & Weinberger, M. C. Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation 59, 643–650 (1979).
Google Scholar
Schmitt, R. & Melk, A. Molecular mechanisms of renal aging. Kidney Int. 92, 569–579 (2017).
Google Scholar
Franzin, R. et al. Targeting premature renal aging: from molecular mechanisms of cellular senescence to senolytic trials. Front. Pharmacol. 12, 630419 (2021).
Google Scholar
Lorenz, E. C. et al. Frailty in CKD and transplantation. Kidney Int. Rep. 6, 2270–2280 (2021).
Google Scholar
Buta, B. J. et al. Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res. Rev. 26, 53–61 (2016).
Google Scholar
Fried, L. P. et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 56, M146–156, (2001).
Google Scholar
Shlipak, M. G. et al. The presence of frailty in elderly persons with chronic renal insufficiency. Am. J. Kidney Dis. 43, 861–867 (2004).
Google Scholar
Ballew, S. H. et al. Frailty, kidney function, and polypharmacy: the atherosclerosis risk in communities (ARIC) study. Am. J. Kidney Dis. 69, 228–236 (2017).
Google Scholar
Wilhelm-Leen, E. R., Hall, Y. N., M, K. T. & Chertow, G. M. Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey. Am. J. Med. 122, 664–671.e662 (2009).
Google Scholar
Roshanravan, B. et al. A prospective study of frailty in nephrology-referred patients with CKD. Am. J. Kidney Dis. 60, 912–921 (2012).
Google Scholar
McAdams-DeMarco, M. A. et al. Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J. Am. Geriatr. Soc. 61, 896–901 (2013).
Google Scholar
Chu, N. M. et al. Frailty prevalence in younger end-stage kidney disease patients undergoing dialysis and transplantation. Am. J. Nephrol. 51, 501–510 (2020).
Google Scholar
McAdams-DeMarco, M. A. et al. Individual frailty components and mortality in kidney transplant recipients. Transplantation 101, 2126–2132 (2017).
Google Scholar
Wenger, U. et al. The relationship between preoperative creatinine clearance and outcomes for patients undergoing liver transplantation: a retrospective observational study. BMC Nephrol. 14, 37 (2013).
Google Scholar
Pugh, J. et al. Frailty and comorbidity are independent predictors of outcome in patients referred for pre-dialysis education. Clin. Kidney J. 9, 324–329 (2016).
Google Scholar
McAdams-DeMarco, M. A. et al. Frailty and cognitive function in incident hemodialysis patients. Clin. J. Am. Soc. Nephrol. 10, 2181–2189 (2015).
Google Scholar
McAdams-DeMarco, M. A. et al. Frailty and falls among adult patients undergoing chronic hemodialysis: a prospective cohort study. BMC Nephrol. 14, 224 (2013).
Google Scholar
McAdams-DeMarco, M. A. et al. Frailty and health-related quality of life in end stage renal disease patients of all ages. J. Frailty Aging 5, 174–179 (2016).
Google Scholar
Lee, S. Y. et al. The prevalence, association, and clinical outcomes of frailty in maintenance dialysis patients. J. Ren. Nutr. 27, 106–112 (2017).
Google Scholar
Hickson, L. J. et al. Hospital readmission among new dialysis patients associated with young age and poor functional status. Nephron 139, 1–12 (2018).
Google Scholar
Alfaadhel, T. A. et al. Frailty and mortality in dialysis: evaluation of a clinical frailty scale. Clin. J. Am. Soc. Nephrol. 10, 832–840 (2015).
Google Scholar
Johansen, K. L. et al. Association of performance-based and self-reported function-based definitions of frailty with mortality among patients receiving hemodialysis. Clin. J. Am. Soc. Nephrol. 11, 626–632 (2016).
Google Scholar
Haugen, C. E. et al. Physical impairment and access to kidney transplantation. Transplantation 104, 367–373 (2020).
Google Scholar
Lorenz, E. C. et al. The relationship between frailty and decreased physical performance with death on the kidney transplant waiting list. Prog. Transpl. 29, 108–114 (2019).
Google Scholar
Cheng, X. S. et al. Physical performance testing in kidney transplant candidates at the top of the waitlist. Am. J. Kidney Dis. 76, 815–825 (2020).
Google Scholar
Lorenz, E. C. et al. Relationship between pre-transplant physical function and outcomes after kidney transplant. Clin. Transplant 31, e12952 (2017).
Google Scholar
Watford, D. J. et al. Toward telemedicine-compatible physical functioning assessments in kidney transplant candidates. Clin. Transpl. 35, e14173 (2021).
Google Scholar
Garonzik-Wang, J. M. et al. Frailty and delayed graft function in kidney transplant recipients. Arch. Surg. 147, 190–193, (2012).
Google Scholar
Kutner, N. G., Zhang, R., Bowles, T. & Painter, P. Pretransplant physical functioning and kidney patients’ risk for posttransplantation hospitalization/death: evidence from a national cohort. Clin. J. Am. Soc. Nephrol. 1, 837–843 (2006).
Google Scholar
McAdams-DeMarco, M. A. et al. Frailty, length of stay, and mortality in kidney transplant recipients: a National Registry and Prospective Cohort Study. Ann. Surg. 266, 1084–1090 (2017).
Google Scholar
McAdams-DeMarco, M. A. et al. Frailty and mortality in kidney transplant recipients. Am. J. Transpl. 15, 149–154 (2015).
Google Scholar
McAdams-DeMarco, M. A. et al. Frailty and early hospital readmission after kidney transplantation. Am. J. Transpl. 13, 2091–2095 (2013).
Google Scholar
McAdams-DeMarco, M. A. et al. Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients. Transplantation 99, 805–810 (2015).
Google Scholar
Reese, P. P. et al. Functional status and survival after kidney transplantation. Transplantation 97, 189–195 (2014).
Google Scholar
Vondracek, S. F., Teitelbaum, I. & Kiser, T. H. Principles of kidney pharmacotherapy for the nephrologist: core curriculum 2021. Am. J. Kidney Dis. 78, 442–458 (2021).
Google Scholar
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105, S117–S314 (2024).
Delanaye, P. et al. CKD: a call for an age-adapted definition. J. Am. Soc. Nephrol. 30, 1785–1805 (2019).
Google Scholar
Levey, A. S. et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 80, 17–28 (2011).
Google Scholar
Hallan, S. I. et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 308, 2349–2360 (2012).
Google Scholar
Wing, L. M. et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N. Engl. J. Med. 348, 583–592 (2003).
Google Scholar
Beckett, N. S. et al. Treatment of hypertension in patients 80 years of age or older. N. Engl. J. Med. 358, 1887–1898 (2008).
Google Scholar
Lithell, H. et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J. Hypertens. 21, 875–886 (2003).
Google Scholar
Granger, C. B. et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 362, 772–776 (2003).
Google Scholar
Heagerty, A. M. & Mallion, J. M. Olmesartan medoxomil in elderly patients with essential or isolated systolic hypertension : efficacy and safety data from clinical trials. Drugs Aging 26, 61–76 (2009).
Google Scholar
Lewis, E. J. et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345, 851–860 (2001).
Google Scholar
Turgut, F., Balogun, R. A. & Abdel-Rahman, E. M. Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations. Clin. J. Am. Soc. Nephrol. 5, 1330–1339 (2010).
Google Scholar
Strippoli, G. F., Craig, M., Deeks, J. J., Schena, F. P. & Craig, J. C. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ 329, 828 (2004).
Google Scholar
Ruggenenti, P., Perna, A. & Remuzzi, G. ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. J. Am. Soc. Nephrol. 12, 2832–2837 (2001).
Google Scholar
Brenner, B. M. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861–869 (2001).
Google Scholar
Hemmelgarn, B. R. et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int. 69, 2155–2161 (2006).
Google Scholar
Bhandari, S. et al. Renin-angiotensin system inhibition in advanced chronic kidney disease. N. Engl. J. Med. 387, 2021–2032 (2022).
Google Scholar
Ahmed, A. K., Kamath, N. S., El Kossi, M. & El Nahas, A. M. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease. Nephrol. Dial. Transpl. 25, 3977–3982 (2010).
Google Scholar
Fu, E. L. et al. Stopping renin-angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: a nationwide study. J. Am. Soc. Nephrol. 32, 424–435 (2021).
Google Scholar
Samiy, A. H. Renal disease in the elderly. Med. Clin. North. Am. 67, 463–480 (1983).
Google Scholar
Chaumont, M. et al. Acute kidney injury in elderly patients with chronic kidney disease: do angiotensin-converting enzyme inhibitors carry a risk? J. Clin. Hypertens. 18, 514–521 (2016).
Google Scholar
Lapi, F., Azoulay, L., Yin, H., Nessim, S. J. & Suissa, S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ 346, e8525 (2013).
Google Scholar
Siew, E. D. et al. Renin-angiotensin aldosterone inhibitor use at hospital discharge among patients with moderate to severe acute kidney injury and its association with recurrent acute kidney injury and mortality. Kidney Int. 99, 1202–1212 (2021).
Google Scholar
Raebel, M. A. et al. Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J. Gen. Intern. Med. 25, 326–333 (2010).
Google Scholar
Kanda, E. et al. Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia. BMC Nephrol. 24, 18 (2023).
Google Scholar
McMurray, J. J. V. et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N. Engl. J. Med. 381, 1995–2008 (2019).
Google Scholar
Packer, M. et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N. Engl. J. Med. 383, 1413–1424 (2020).
Google Scholar
Anker, S. D. et al. Empagliflozin in heart failure with a preserved ejection fraction. N. Engl. J. Med. 385, 1451–1461 (2021).
Google Scholar
Perkovic, V. et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N. Engl. J. Med. 380, 2295–2306 (2019).
Google Scholar
Heerspink, H. J. L. et al. Dapagliflozin in patients with chronic kidney disease. N. Engl. J. Med. 383, 1436–1446 (2020).
Google Scholar
9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2021. Diabetes Care 44, S111–S124 (2021).
Monteiro, P. et al. Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial. Age Ageing 48, 859–866 (2019).
Google Scholar
Cahn, A. et al. Efficacy and safety of dapagliflozin in the elderly: analysis from the DECLARE-TIMI 58 study. Diabetes Care 43, 468–475 (2020).
Google Scholar
Giugliano, D. et al. Efficacy of SGLT-2 inhibitors in older adults with diabetes: systematic review with meta-analysis of cardiovascular outcome trials. Diabetes Res. Clin. Pract. 162, 108114 (2020).
Google Scholar
Vart, P. et al. Efficacy and safety of dapagliflozin in patients with chronic kidney disease across the spectrum of frailty. J. Gerontol. A Biol. Sci. Med. Sci. 79, glad181 (2024).
Google Scholar
Pratley, R. E. et al. Cardiorenal outcomes, kidney function, and other safety outcomes with ertugliflozin in older adults with type 2 diabetes (VERTIS CV): secondary analyses from a randomised, double-blind trial. Lancet Healthy Longev. 4, e143–e154 (2023).
Google Scholar
Yen, F. S. et al. Sodium-glucose cotransporter-2 inhibitors and the risk for dialysis and cardiovascular disease in patients with stage 5 chronic kidney disease. Ann. Intern. Med. (2024).
Takahashi, Y., Seino, Y. & Yabe, D. Long-term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes. J. Diabetes Investig. 15, 63–66 (2024).
Google Scholar
Op den Kamp, Y. J. M. et al. Effects of the SGLT2 inhibitor dapagliflozin on energy metabolism in patients with type 2 diabetes: a randomized, double-blind crossover trial. Diabetes Care 44, 1334–1343 (2021).
Google Scholar
Kamei, S. et al. Effect of tofogliflozin on body composition and glycemic control in Japanese subjects with type 2 diabetes mellitus. J. Diabetes Res. 2018, 6470137 (2018).
Google Scholar
Zhang, S., Qi, Z., Wang, Y., Song, D. & Zhu, D. Effect of sodium-glucose transporter 2 inhibitors on sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Front. Endocrinol. 14, 1203666 (2023).
Google Scholar
Yabe, D. et al. Efficacy and safety of the sodium-glucose co-transporter-2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: a randomized, double-blind, placebo-controlled, 52-week clinical trial (EMPA-ELDERLY). Diabetes Obes. Metab. 25, 3538–3548 (2023).
Google Scholar
Mone, P. et al. Empagliflozin improves cognitive impairment in frail older adults with type 2 diabetes and heart failure with preserved ejection fraction. Diabetes Care 45, 1247–1251 (2022).
Google Scholar
Marx, N., Husain, M., Lehrke, M., Verma, S. & Sattar, N. GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes. Circulation 146, 1882–1894 (2022).
Google Scholar
Sattar, N. et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol. 9, 653–662 (2021).
Google Scholar
Perkovic, V. et al. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N. Engl. J. Med. (2024).
Gilbert, M. P. et al. Effect of liraglutide on cardiovascular outcomes in elderly patients: a post hoc analysis of a randomized controlled trial. Ann. Intern. Med. 170, 423–426 (2019).
Google Scholar
Leiter, L. A. et al. Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial. Cardiovasc. Diabetol. 18, 73 (2019).
Google Scholar
Abdelhafiz, A. H. & Sinclair, A. J. Cardio-renal protection in older people with diabetes with frailty and medical comorbidities — a focus on the new hypoglycaemic therapy. J. Diabetes Complications 34, 107639 (2020).
Google Scholar
Patorno, E. et al. Comparative effectiveness and safety of sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide 1 receptor agonists in older adults. Diabetes Care 44, 826–835 (2021).
Google Scholar
Kutz, A. et al. Comparative cardiovascular effectiveness and safety of SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors according to frailty in type 2 diabetes. Diabetes Care 46, 2004–2014 (2023).
Google Scholar
Simms-Williams, N. et al. Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. BMJ 385, e078242 (2024).
Google Scholar
Bach, V., Schruckmayer, G., Sam, I., Kemmler, G. & Stauder, R. Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort. Clin. Interv. Aging 9, 1187–1196 (2014).
Google Scholar
Stauffer, M. E. & Fan, T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One 9, e84943 (2014).
Google Scholar
Locatelli, F. et al. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol. Dial. Transpl. 19, 121–132 (2004).
Google Scholar
Hoshino, J. et al. Associations of hemoglobin levels with health-related quality of life, physical activity, and clinical outcomes in persons with stage 3-5 nondialysis CKD. J. Ren. Nutr. 30, 404–414 (2020).
Google Scholar
Ku, E. et al. Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 104, 655–680 (2023).
Google Scholar
Farag, Y. M. K. et al. Effect of anemia on physical function and physical activity in CKD: the National Health and Nutrition Examination Survey, 1999–2016. Kidney360 4, e1212–e1222 (2023).
Google Scholar
Haase, V. H. Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease. Kidney Int. Suppl. 11, 8–25 (2021).
Google Scholar
Chappell, J. C., Payne, L. B. & Rathmell, W. K. Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers. J. Clin. Invest. 129, 442–451 (2019).
Google Scholar
Benfante, R. & Reed, D. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA 263, 393–396 (1990).
Google Scholar
Lewington, S. et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370, 1829–1839, (2007).
Google Scholar
Shepherd, J. et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360, 1623–1630 (2002).
Google Scholar
Vidt, D. G. et al. Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate. Am. J. Cardiol. 97, 1602–1606 (2006).
Google Scholar
Masnoon, N., Shakib, S., Kalisch-Ellett, L. & Caughey, G. E. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 17, 230 (2017).
Google Scholar
Onor, I. O. et al. Polypharmacy in chronic kidney disease: health outcomes & pharmacy-based strategies to mitigate inappropriate polypharmacy. Am. J. Med. Sci. 367, 4–13 (2024).
Google Scholar
Gnjidic, D. et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin. Pharmacol. Ther. 91, 521–528 (2012).
Google Scholar
Jamsen, K. M. et al. Effects of changes in number of medications and drug burden index exposure on transitions between frailty states and death: the concord health and ageing in men project cohort study. J. Am. Geriatr. Soc. 64, 89–95 (2016).
Google Scholar
Saum, K. U. et al. Is polypharmacy associated with frailty in older people? Results from the ESTHER cohort study. J. Am. Geriatr. Soc. 65, e27–e32 (2017).
Google Scholar
Trevisan, C. et al. Factors influencing transitions between frailty states in elderly adults: the Progetto Veneto Anziani Longitudinal Study. J. Am. Geriatr. Soc. 65, 179–184 (2017).
Google Scholar
Bonaga, B. et al. Frailty, polypharmacy, and health outcomes in older adults: the frailty and dependence in albacete study. J. Am. Med. Dir. Assoc. 19, 46–52 (2018).
Google Scholar
Moulis, F. et al. Searching for a polypharmacy threshold associated with frailty. J. Am. Med. Dir. Assoc. 16, 259–261 (2015).
Google Scholar
Gnjidic, D. et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J. Clin. Epidemiol. 65, 989–995 (2012).
Google Scholar
Scott, I. A. et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern. Med. 175, 827–834, (2015).
Google Scholar
McIntyre, C., McQuillan, R., Bell, C. & Battistella, M. Targeted deprescribing in an outpatient hemodialysis unit: a quality improvement study to decrease polypharmacy. Am. J. Kidney Dis. 70, 611–618 (2017).
Google Scholar
Thomas, M. C. Diuretics, ACE inhibitors and NSAIDs — the triple whammy. Med. J. Aust. 172, 184–185 (2000).
Google Scholar
Dahmke, H. et al. Evaluation of triple whammy prescriptions after the implementation of a drug safety algorithm. Drugs Real. World Outcomes 11, 125–135 (2024).
Google Scholar
Seiberth, S., Berner, J., Hug, M. J. & Strobach, D. Double Whamm’ and ‘Triple Whamm’ combinations in hospitalized surgical patients — real life data from a tertiary teaching hospital. Pharmazie 77, 38–43 (2022).
Google Scholar
Camin, R. M. et al. Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors, diuretics and NSAIDS: “The Triple Whammy”. Nefrologia 35, 197–206 (2015).
Google Scholar
Nochaiwong, S. et al. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis. Nephrol. Dial. Transpl. 33, 331–342 (2018).
Google Scholar
Geevasinga, N., Coleman, P. L., Webster, A. C. & Roger, S. D. Proton pump inhibitors and acute interstitial nephritis. Clin. Gastroenterol. Hepatol. 4, 597–604 (2006).
Google Scholar
Simpson, I. J. et al. Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases. Nephrology 11, 381–385 (2006).
Google Scholar
Roshanravan, B. et al. Association between physical performance and all-cause mortality in CKD. J. Am. Soc. Nephrol. 24, 822–830 (2013).
Google Scholar
Doyle, E. M. et al. Association between kidney function, rehabilitation outcome, and survival in older patients discharged from inpatient rehabilitation. Am. J. Kidney Dis. 66, 768–774 (2015).
Google Scholar
Heiwe, S. & Jacobson, S. H. Exercise training in adults with CKD: a systematic review and meta-analysis. Am. J. Kidney Dis. 64, 383–393 (2014).
Google Scholar
Castaneda, C. et al. Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency. A randomized, controlled trial. Ann. Intern. Med. 135, 965–976 (2001).
Google Scholar
Castaneda, C. et al. Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. Am. J. Kidney Dis. 43, 607–616 (2004).
Google Scholar
Watson, E. L. et al. Progressive resistance exercise training in CKD: a feasibility study. Am. J. Kidney Dis. 66, 249–257 (2015).
Google Scholar
Balakrishnan, V. S. et al. Resistance training increases muscle mitochondrial biogenesis in patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 5, 996–1002 (2010).
Google Scholar
Gregory, S. M. et al. Lack of circulating bioactive and immunoreactive IGF-I changes despite improved fitness in chronic kidney disease patients following 48 weeks of physical training. Growth Horm. IGF Res. 21, 51–56 (2011).
Google Scholar
Headley, S. et al. Exercise training improves HR responses and V˙O2peak in predialysis kidney patients. Med. Sci. Sports Exerc. 44, 2392–2399 (2012).
Google Scholar
Howden, E. J. et al. Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clin. J. Am. Soc. Nephrol. 8, 1494–1501 (2013).
Google Scholar
Howden, E. J. et al. Exercise training in CKD: efficacy, adherence, and safety. Am. J. Kidney Dis. 65, 583–591 (2015).
Google Scholar
Greenwood, S. A. et al. Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial. Am. J. Kidney Dis. 65, 425–434 (2015).
Google Scholar
Leehey, D. J. et al. Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. Am. J. Nephrol. 44, 54–62 (2016).
Google Scholar
Chen, I. R. et al. Association of walking with survival and RRT among patients with CKD stages 3–5. Clin. J. Am. Soc. Nephrol. 9, 1183–1189 (2014).
Google Scholar
Shlipak, M. G. et al. Effect of structured, moderate exercise on kidney function decline in sedentary older adults: an ancillary analysis of the LIFE study randomized clinical trial. JAMA Intern. Med. 182, 650–659, (2022).
Google Scholar
Deutz, N. E. et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin. Nutr. 33, 929–936 (2014).
Google Scholar
Bauer, J. et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J. Am. Med. Dir. Assoc. 14, 542–559 (2013).
Google Scholar
Deer, R. R. & Volpi, E. Protein intake and muscle function in older adults. Curr. Opin. Clin. Nutr. Metab. Care 18, 248–253 (2015).
Google Scholar
Klahr, S. et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N. Engl. J. Med. 330, 877–884 (1994).
Google Scholar
Levey, A. S. et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am. J. Kidney Dis. 27, 652–663 (1996).
Google Scholar
Yan, B., Su, X., Xu, B., Qiao, X. & Wang, L. Effect of diet protein restriction on progression of chronic kidney disease: a systematic review and meta-analysis. PLoS One 13, e0206134 (2018).
Google Scholar
Moore, L. W. et al. The mean dietary protein intake at different stages of chronic kidney disease is higher than current guidelines. Kidney Int. 83, 724–732 (2013).
Google Scholar
Koppe, L. & Fouque, D. The role for protein restriction in addition to renin-angiotensin-aldosterone system inhibitors in the management of CKD. Am. J. Kidney Dis. 73, 248–257 (2019).
Google Scholar
Narasaki, Y., Rhee, C. M., Kramer, H. & Kalantar-Zadeh, K. Protein intake and renal function in older patients. Curr. Opin. Clin. Nutr. Metab. Care 24, 10–17 (2021).
Google Scholar
Lee, S. W. et al. Dietary protein intake, protein energy wasting, and the progression of chronic kidney disease: analysis from the KNOW-CKD study. Nutrients 11, 121 (2019).
Google Scholar
Phillips, S. M., Paddon-Jones, D. & Layman, D. K. Optimizing adult protein intake during catabolic health conditions. Adv. Nutr. 11, S1058–s1069 (2020).
Google Scholar
Krok-Schoen, J. L., Archdeacon Price, A., Luo, M., Kelly, O. J. & Taylor, C. A. Low dietary protein intakes and associated dietary patterns and functional limitations in an aging population: a NHANES analysis. J. Nutr. Health Aging 23, 338–347 (2019).
Google Scholar
O’Hare, A. M. et al. Age affects outcomes in chronic kidney disease. J. Am. Soc. Nephrol. 18, 2758–2765 (2007).
Google Scholar
Obi, Y. et al. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. Clin. J. Am. Soc. Nephrol. 5, 1558–1565 (2010).
Google Scholar
Koppe, L., Cassani de Oliveira, M. & Fouque, D. Ketoacid analogues supplementation in chronic kidney disease and future perspectives. Nutrients 11, 2071 (2019).
Google Scholar
Li, A., Lee, H. Y. & Lin, Y. C. The effect of ketoanalogues on chronic kidney disease deterioration: a meta-analysis. Nutrients 11, 957 (2019).
Google Scholar
Liu, D. et al. Low-protein diet supplemented with ketoacids delays the progression of diabetic nephropathy by inhibiting oxidative stress in the KKAy mice model. Br. J. Nutr. 119, 22–29 (2018).
Google Scholar
Di Iorio, B. R. et al. Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease. Nephrol. Dial. Transpl. 33, 804–813 (2018).
Google Scholar
Milovanova, L. et al. Effect of essential amino acid кetoanalogues and protein restriction diet on morphogenetic proteins (FGF-23 and Кlotho) in 3b-4 stages chronic кidney disease patients: a randomized pilot study. Clin. Exp. Nephrol. 22, 1351–1359 (2018).
Google Scholar
Wang, M. et al. Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways. J. Transl. Med. 17, 122 (2019).
Google Scholar
Garibotto, G. et al. Effects of low-protein, and supplemented very low-protein diets, on muscle protein turnover in patients with CKD. Kidney Int. Rep. 3, 701–710 (2018).
Google Scholar
Bellizzi, V. et al. Safety and effectiveness of low-protein diet supplemented with ketoacids in diabetic patients with chronic kidney disease. BMC Nephrol. 19, 110 (2018).
Google Scholar
Brunori, G. et al. Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. Am. J. Kidney Dis. 49, 569–580 (2007).
Google Scholar
Chewcharat, A. et al. The effects of restricted protein diet supplemented with ketoanalogue on renal function, blood pressure, nutritional status, and chronic kidney disease — mineral and bone disorder in chronic kidney disease patients: a systematic review and meta-analysis. J. Ren. Nutr. 30, 189–199 (2020).
Google Scholar
Stremke, E. R., Biruete, A. & Hill Gallant, K. M. Dietary protein intake and bone across stages of chronic kidney disease. Curr. Osteoporos. Rep. 18, 247–253 (2020).
Google Scholar
Kamper, A. L. & Strandgaard, S. Long-term effects of high-protein diets on renal function. Annu. Rev. Nutr. 37, 347–369 (2017).
Google Scholar
Mafra, D. et al. Food as medicine: targeting the uraemic phenotype in chronic kidney disease. Nat. Rev. Nephrol. 17, 153–171 (2021).
Google Scholar
Mirmiran, P. et al. A prospective study of dietary meat intake and risk of incident chronic kidney disease. J. Ren. Nutr. 30, 111–118 (2020).
Google Scholar
Heo, G. Y. et al. Association of plant protein intake with risk of incident CKD: a UK Biobank Study. Am. J. Kidney Dis. 82, 687–697.e1 (2023).
Google Scholar
NIDDK, National Institutes of Health. 2023 USRDS annual data report: epidemiology of kidney disease in the United States. (2023).
Japanese Society for Dialysis Therapy. Current status of dialysis therapy in Japan [in Japanese]. (2022).
Sparke, C. et al. Estimating the total incidence of kidney failure in Australia including individuals who are not treated by dialysis or transplantation. Am. J. Kidney Dis. 61, 413–419 (2013).
Google Scholar
Wakasugi, M. & Narita, I. Estimating the rate of withholding dialysis from elderly people aged ≥85 years in Japan (Japanese). Jpn. J. Nephrol. 61, 91–97 (2019).
Wachterman, M. W. et al. End-of-life experience of older adults dying of end-stage renal disease: a comparison with cancer. J. Pain. Symptom Manag. 54, 789–797 (2017).
Google Scholar
Abdel-Kader, K., Unruh, M. L. & Weisbord, S. D. Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin. J. Am. Soc. Nephrol. 4, 1057–1064 (2009).
Google Scholar
Schaeffner, E. Smoothing transition to dialysis to improve early outcomes after dialysis initiation among old and frail adults — a narrative review. Nephrol. Dial. Transpl. 37, 2307–2313 (2022).
Google Scholar
Hansen, M. S. et al. Psychosocial factors affecting patients with end-stage kidney disease and the impact of the social worker. J. Nephrol. 35, 43–58 (2022).
Google Scholar
Jassal, S. V., Chiu, E. & Hladunewich, M. Loss of independence in patients starting dialysis at 80 years of age or older. N. Engl. J. Med. 361, 1612–1613 (2009).
Google Scholar
Saran, R. et al. US renal data system 2018 annual data report: epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 73, A7–a8 (2019).
Google Scholar
Murphy, E., Germain, M. J., Cairns, H., Higginson, I. J. & Murtagh, F. E. International variation in classification of dialysis withdrawal: a systematic review. Nephrol. Dial. Transpl. 29, 625–635 (2014).
Google Scholar
Buemi, M. et al. Dialysis and the elderly: an underestimated problem. Kidney Blood Press. Res. 31, 330–336 (2008).
Google Scholar
Kurella Tamura, M. Incidence, management, and outcomes of end-stage renal disease in the elderly. Curr. Opin. Nephrol. Hypertens. 18, 252–257 (2009).
Google Scholar
Robinson, B. M. et al. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int. 85, 158–165 (2014).
Google Scholar
Saran, R. et al. US renal data system 2017 annual data report: epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 71, A7 (2018).
Google Scholar
Wachterman, M. W. et al. One-year mortality after dialysis initiation among older adults. JAMA Intern. Med. 179, 987–990, (2019).
Google Scholar
Wong, S. P., Kreuter, W. & O’Hare, A. M. Treatment intensity at the end of life in older adults receiving long-term dialysis. Arch. Intern. Med. 172, 661–663 (2012). discussion 663–664.
Google Scholar
Thapa, S., Jardine, T., Davids, T., Caskey, F. J. & Davids, M. R. Incidence and 1-year survival of elderly South Africans starting kidney replacement therapy. Kidney Int. Rep. 7, 2071–2075 (2022).
Google Scholar
Himmelfarb, J., Vanholder, R., Mehrotra, R. & Tonelli, M. The current and future landscape of dialysis. Nat. Rev. Nephrol. 16, 573–585 (2020).
Google Scholar
International Society of Nephrology. ISN-global kidney health atlas 2023. (2023).
Marrón, B., Remón, C., Pérez-Fontán, M., Quirós, P. & Ortíz, A. Benefits of preserving residual renal function in peritoneal dialysis. Kidney Int. Suppl. 108, S42–S51 (2008).
Google Scholar
Brown, E. A. et al. Burden of kidney disease, health-related quality of life, and employment among patients receiving peritoneal dialysis and in-center hemodialysis: findings from the DOPPS program. Am. J. Kidney Dis. 78, 489–500.e1 (2021).
Google Scholar
Brown, E. A. et al. Broadening options for long-term dialysis in the elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol. Dial. Transpl. 25, 3755–3763 (2010).
Google Scholar
Iyasere, O. U. et al. Quality of life and physical function in older patients on dialysis: a comparison of assisted peritoneal dialysis with hemodialysis. Clin. J. Am. Soc. Nephrol. 11, 423–430 (2016).
Google Scholar
Harris, S. A., Lamping, D. L., Brown, E. A. & Constantinovici, N. Clinical outcomes and quality of life in elderly patients on peritoneal dialysis versus hemodialysis. Perit. Dial. Int. 22, 463–470 (2002).
Google Scholar
Iyasere, O. et al. Longitudinal trends in quality of life and physical function in frail older dialysis patients: a comparison of assisted peritoneal dialysis and in-center hemodialysis. Perit. Dial. Int. 39, 112–118 (2019).
Google Scholar
Han, S. S. et al. Dialysis modality and mortality in the elderly: a meta-analysis. Clin. J. Am. Soc. Nephrol. 10, 983–993 (2015).
Google Scholar
Cheng, L., Hu, N., Song, D. & Chen, Y. Mortality of peritoneal dialysis versus hemodialysis in older adults: an updated systematic review and meta-analysis. Gerontology 70, 461–478 (2024).
Google Scholar
Heaf, J. et al. First-year mortality in incident dialysis patients: results of the Peridialysis study. BMC Nephrol. 23, 229 (2022).
Google Scholar
Etgen, T., Chonchol, M., Förstl, H. & Sander, D. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am. J. Nephrol. 35, 474–482 (2012).
Google Scholar
Foster, R. et al. Cognitive impairment in advanced chronic kidney disease: the Canadian frailty observation and interventions trial. Am. J. Nephrol. 44, 473–480 (2016).
Google Scholar
Lambie, M. et al. Starting and withdrawing haemodialysis-associations between nephrologists’ opinions, patient characteristics and practice patterns (data from the Dialysis Outcomes and Practice Patterns Study). Nephrol. Dial. Transpl. 21, 2814–2820 (2006).
Google Scholar
Ngandu, T. et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385, 2255–2263 (2015).
Google Scholar
Livingston, G. et al. Dementia prevention, intervention, and care. Lancet 390, 2673–2734 (2017).
Google Scholar
Sprick, J. D. et al. Cerebral blood flow regulation in end-stage kidney disease. Am. J. Physiol. Renal Physiol. 319, F782–F791 (2020).
Google Scholar
Wolfgram, D. F., Szabo, A., Murray, A. M. & Whittle, J. Risk of dementia in peritoneal dialysis patients compared with hemodialysis patients. Perit. Dial. Int. 35, 189–198 (2015).
Google Scholar
Neumann, D., Mau, W., Wienke, A. & Girndt, M. Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course. Kidney Int. 93, 430–438 (2018).
Google Scholar
Tian, X. et al. The comparison of cognitive function and risk of dementia in CKD patients under peritoneal dialysis and hemodialysis: a PRISMA-compliant systematic review and meta-analysis. Medicine 98, e14390 (2019).
Google Scholar
Ali, H. et al. The effects of dialysis modality choice on cognitive functions in patients with end-stage renal failure: a systematic review and meta-analysis. Int. Urol. Nephrol. 53, 155–163 (2021).
Google Scholar
Kielstein, J. T. et al. ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 37, 2024–2029 (2006).
Google Scholar
Fleetwood, V. A., Caliskan, Y., Rub, F. A. A., Axelrod, D. & Lentine, K. L. Maximizing opportunities for kidney transplantation in older adults. Curr. Opin. Nephrol. Hypertens. 32, 204–211 (2023).
Google Scholar
Wolfe, R. A. et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 341, 1725–1730 (1999).
Google Scholar
Oniscu, G. C., Brown, H. & Forsythe, J. L. How great is the survival advantage of transplantation over dialysis in elderly patients? Nephrol. Dial. Transpl. 19, 945–951 (2004).
Google Scholar
U.S. Organ Procurement and Transplantation Network: 2014 Annual Report of Department of Health and Human Services, Health Resources and Services Administration. (2014).
Serrano, O. K. et al. Age alone is not a contraindication to kidney donation: outcomes of donor nephrectomy in the elderly. Clin. Transpl. 32, e13287 (2018).
Google Scholar
Bae, S. et al. Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor-recipient combination. Am. J. Transpl. 19, 425–433 (2019).
Google Scholar
McAdams-DeMarco, M. A. et al. Changes in frailty after kidney transplantation. J. Am. Geriatr. Soc. 63, 2152–2157 (2015).
Google Scholar
Farrington, K. et al. Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR<45 mL/min/1.73 m2): a summary document from the European Renal Best Practice Group. Nephrol. Dial. Transpl. 32, 9–16 (2017).
Google Scholar
Buur, L. E. et al. Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review. BMC Nephrol. 22, 307 (2021).
Google Scholar
Unit, O. K. A Guide to Conservative Kidney Management. Oxford Kidney Unit. (2018).
Davison, S. N. et al. Recommendations for the care of patients receiving conservative kidney management: focus on management of CKD and symptoms. Clin. J. Am. Soc. Nephrol. 14, 626–634 (2019).
Google Scholar
Wong, S. P. Y. et al. Long-term outcomes among patients with advanced kidney disease who forgo maintenance dialysis: a systematic review. JAMA Netw. Open. 5, e222255 (2022).
Google Scholar
Liu, C. K. & Kurella Tamura, M. Conservative care for kidney failure-the other side of the coin. JAMA Netw. Open. 5, e222252 (2022).
Google Scholar
Murakami, N., Reich, A. J., Pavlakis, M. & Lakin, J. R. Conservative kidney management in kidney transplant populations. Semin. Nephrol. 43, 151401 (2023).
Google Scholar
Lai, C. F. et al. Withdrawal from long-term hemodialysis in patients with end-stage renal disease in Taiwan. J. Formos. Med. Assoc. 112, 589–599 (2013).
Google Scholar
Japan Agency for Medical Research and Development (AMED) Longevity Science Research Project. Conservative Kidney Management (CKM) — concepts and practice for elderly patients with kidney failure. (2022).
Chen, C., Ding, S. & Wang, J. Digital health for aging populations. Nat. Med. 29, 1623–1630 (2023).
Google Scholar
Jinagal, J. & Dhiman, P. Retraction: retinal hemorrhage from blunt ocular trauma. N. Engl. J. Med. 382, 490 (2019).
Google Scholar
Gurz, D. et al. The impact of virtual reality (VR) gaming and casual/social gaming on the quality of life, depression, and dialysis tolerance in patients with chronic kidney disease: a narrative review. Cureus 15, e44904 (2023).
Google Scholar
link
